S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling
โ Scribed by Ryosuke Nemoto; Kazunori Hattori; Katsunori Uchida; Toru Shimazui; Yukiko Nishijima; Kenkichi Koiso; Masaoki Harada
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 619 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Our purpose was to evaluate the relationship of Ki-67 labeling index (Ki67-LI) to deoxyribonucleic acid (DNA) ploidy, S phase fraction (SPF), other clinical prognostic factors, and clinical outcome for patients with prostate cancer treated by external beam radiotherapy. METHODS. Tis
## Background: The prognostic significance of primary tumor dna-ploidy and s-phase fraction (spf) was evaluated in patients treated with androgen ablation for regionally localized node-positive prostate cancer. ## Methods: All patients were diagnosed with lymph node involvement by pelvic lymphade